doi.org/10.1182/blood.2019003633
Other

Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria

..., Stefan Schönland
50
Blood21.00
Volume: 135, Issue: 18, Pages: 1517 - 1530
Published: Feb 27, 2020
Paper Fields
Paper Details
Title
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria
DOI
doi.org/10.1182/blood.2019003633
Published Date
Feb 27, 2020
Journal
Blood
Volume
135
Issue
18
Pages
1517 - 1530
© 2025 Pluto Labs All rights reserved.